Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1Dermatologic 1

Conditions

Leukemia 65Myelodysplastic Syndromes 64Leukemia, Myeloid, Acute 55Precursor Cell Lymphoblastic Leukemia-Lymphoma 43Lymphoma 41Leukemia, Lymphocytic, Chronic, B-Cell 40Multiple Myeloma 35Hodgkin Disease 35Lymphoma, Non-Hodgkin 34Leukemia, Myeloid, Chronic-Phase 34Myeloproliferative Disorders 33Leukemia, Myeloid, Accelerated Phase 31Lymphoma, Follicular 28Lymphoma, B-Cell, Marginal Zone 28Congenital Abnormalities 28Burkitt Lymphoma 28Lymphoma, Mantle-Cell 27Lymphoma, Large B-Cell, Diffuse 27Neoplasms, Plasma Cell 23Lymphoma, Large-Cell, Immunoblastic 23Anemia, Refractory, with Excess of Blasts 23Blast Crisis 22Myelodysplastic-Myeloproliferative Diseases 19Leukemia, Myelomonocytic, Chronic 19Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 19Graft vs Host Disease 19Dendritic Cell Sarcoma, Interdigitating 19Primary Myelofibrosis 17Waldenstrom Macroglobulinemia 14Recurrence 14

Interventions

Voriconazole 4Caspofungin 4posaconazole 3Fluconazole 3Itraconazole 2Amphotericin B 2liposomal amphotericin B 1Standard of Care 1ProMune 1Lymphatic Irradiation 1Levofloxacin 1Cyclosporine 1Antilymphocyte Serum 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Mycoses × Antilymphocyte Serum × Clear all
NCT00896493 2023-05-11

Ph II of Non-myeloablative Allogeneic Transplantation Using TLI & ATG In Patients w/ Cutaneous T Cell Lymphoma

Stanford University

Phase 2 Completed
38 enrolled 21 charts
DermatologicLymphoid

Lymphoma, Non-Hodgkin, Mycoses, Sezary Syndrome, Lymphoma, T-Cell, Cutaneous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡